Elevai Labs, Inc. - Common Stock
(NQ:
ELAB
)
0.1080
-0.0240 (-18.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elevai Labs, Inc. - Common Stock
< Previous
1
2
3
Next >
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
October 04, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
October 04, 2024
Via
Benzinga
11 Consumer Staples Stocks Moving In Friday's Intraday Session
October 04, 2024
Via
Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
October 04, 2024
Via
Benzinga
Why Elevai Labs (ELAB) Stock Is Down 60% Today
September 23, 2024
Elevai Labs shares are trading lower by 60% Monday morning. The company announced the pricing of an $8.0 million public offering.
Via
Benzinga
ELAB Stock Earnings: Elevai Labs Reported Results for Q2 2024
August 14, 2024
Elevai Labs just reported results for the second quarter of 2024.
Via
InvestorPlace
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
October 03, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Nasdaq Moves Lower; Levi Strauss Shares Slide
October 03, 2024
Via
Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
October 03, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
October 03, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via
Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
October 03, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
October 02, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
7 Penny Stocks to Watch Now: ELAB, RJDG, BTTC, ATCH, CBDW, and More!
September 25, 2024
Via
AB Newswire
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
September 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
September 23, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Edge Higher; Chicago Fed National Activity Increases In August
September 23, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering
September 23, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications
September 10, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
September 04, 2024
Via
Benzinga
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
September 03, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Monday's After-Market Session
September 02, 2024
Via
Benzinga
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
August 28, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
August 26, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
August 26, 2024
Via
Benzinga
Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 23, 2024
Via
Benzinga
Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
August 19, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
July 30, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.